A Medical Device Daily

OSI Systems (Hawthorne, California), said that its Optoelectronics and Manufacturing division, OSI Optoelectronics, has received an approximate $10.5 million OEM contract from an unnamed international Fortune 500 medical equipment company to provide detector electronic sub-assemblies.

The detector electronic sub-assemblies are to be used by the customer in a 64-slice medical CT machine. Shipment of the assemblies has already begun and is expected to be completed in fiscal 2007.

OSI Optoelectronics will manufacture semiconductor photodiodes at its Wafer Processing Center in Hawthorne with the final subsystem detector electronic module being produced through its Norwegian subsidiary, Advanced Micro Electronics As.

OSI Systems is a maker of security and inspection systems, medical monitoring and anesthesia products, optoelectronic devices and value-added subsystems.

Strategic Diagnostics (Newark, Delaware) said that it has signed a new agreement to supply bio-reagents to a large manufacturer of in vitro diagnostics. The initial term of the agreement is five years. Starting revenues are estimated at $1 million per year and are anticipated to more than double over the term of the agreement. Strategic Diagnostics will begin shipping bio-reagents to the customer in 4Q06.

Strategic Diagnostics makes biotechnology-based detection solutions to a diverse customer base, across multiple industrial and human health markets.

In other agreement news,I-Flow (Lake Forest, California) reported an agreement with Amerinet (St. Louis) to make the ON-Q line of post-surgical pain relief devices available to its member facilities. The contract includes the ON-Q PainBuster Post-Operative Pain Relief System, the ON-Q C-bloc Continuous Nerve Block System and the ON-Q SilverSoaker Catheter. Patients treated with ON-Q experience significantly better pain relief than with narcotics alone following surgery and need significantly less narcotics during their recovery so they often get back to normal faster after their surgery.

Amerinet serves more than 2,100 hospitals and 40,000 non-acute care facilities nationwide.

ON-Q is now labeled to “significantly reduce pain better than narcotics and to significantly reduce narcotics intake after surgery,” the company said.